
15 April 2026 - The agency wants these devices to show meaningful improvement over existing alternatives.
The Centers for Medicare and Medicaid Services is proposing to repeal a pathway that currently allows breakthrough devices to qualify for supplementary payments without proving they provide a substantial clinical improvement over alternatives.